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Two glycosylinositol phosphates related to putative insulin mimetics, 6-0-(2-amino-2-deoxy-a-~- 
glucopyranosy1)-D-chiro-inositol 1-phosphate (1) and 6-0-(2-amino-2-deoxy-a-~-glucopyranosyl)-~- 
myo-inositol 1-phosphate (2), have been synthesized from selectively protected and enantiomerically 
pure D-chiro- and myo-inositol derivatives. The D-chiro-inositol unit was prepared in a multigram 
scale from D-glucose using the Ferrier's carbocyclization route, and it was transformed into the 
corresponding my0 epimer by an oxidation-reduction sequence. The trichloroacetimidate method 
was applied efficiently for the key glycosylation of the inositol derivatives. 
It has been proposed that the plasma membrane contains 
glycosylphosphatidylinositols (GPIs) which are cleaved 
by phosphatidylinositol specific phospholipase C (PI-PLC) 
or D (PI-PLD) to release phosphoinositol phosphoglycans 
or inositol phosphoglycans, respectively. These released 
glycans may act as mediators of a variety of enzyme 
pathways.l The most thoroughly studied system is the 
cleavage of GPI after binding of insulin in hepatocytes, 
adipocytes, or myocytes.2 Binding of insulin to these target 
cells results in the PI-PLC or PI-PLD mediated cleavage 
of a GPI to release a phosphoinositol phosphoglycan or 
inositol phosphoglycan, respectively, which seem to act as 
second messengers of insulin action.2 These compounds 
have also been reported to mediate the action of inter- 
leukine 2,3 insulin-like growth factor: and nerve growth 
factor.5 
The precise chemical structure of these putative media- 
tors has not been elucidated yet, but present evidence 
indicates that it could be related to those of the GPIs 
which anchor proteins, polysaccharides, or small oligosac- 
charides to the outer face of cellular membranes through 
a covalent linkage.6 At  least two structurally distinct 
mediators have been r e p ~ r t e d . ~ ~ ~ ~  The first one inhibited 
CAMP-dependent protein kinase and contained myo- 
inositol and chiro-inositol, 2-amino-2-deoxy-~-glucose, 
galactose, and phosphate.2i The second type stimulated 
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pyruvate dehydrogenase kinase and contained D-chiro- 
inositol, 2-amho-2-deoxy-~-galactose, mannose, and phos- 
 hate.^ These results have been taken as an indication of 
the existence of a family of compounds with different 
biological activities rather than a unique phosphoglycan 
m e d i a t ~ r . ~ ' ~ ~  In agreement with this, we have recently 
determined partial structures of insulin mediators from 
bovine liver which contained a variable number of phos- 
phorylated a-galactose residues, N-acetylglucosamine or 
-galactosamine, non-ZV-acetylated glucosamine, and inosi- 
tol.* 
The determination of the structure of this potentially 
important family of compounds is seriously hampered by 
the minute amounts of active material present in the 
biological sources from which they have to be isolated. 
The development of effective and versatile strategies for 
the preparation of building blocks which could be used for 
the synthesis of different structures required for biological 
experiments is, therefore, necessary. In this context, we 
are involved in work directed to establish these strategiesgJ0 
and have reported on an efficient route leading to glycosyl- 
myo-inositol 1-phosphate starting from myo-inositol.'Oa 
We have developed a different route for the synthesis of 
glycosyl-D-chiro-inositol 1-phosphates, that can also be 
used for the synthesis of glycosyl-myo-inositol l-phos- 
phates, in which the inositol unit is prepared from 
D-glUCOSe.g We now report the synthesis of 6-0-(2-amino- 
2-deoxy-a-~-glucopyranosyl)-~-chiro-inositoll-phosphate 
(1) and 6-~-(2-am~no-2-deoxy-a-D-glucopyranosyl)-D-myo- 
inositol 1-phosphate (2) following this synthetic strategy. 
The complete sequence leading to 1 has been optimized 
and permits the preparation of sufficient material to be 
used in biological investigation. Synthesis of several 
fragments and the complete glycosylphosphatidylinositol 
anchor of the variant surface glycoprotein of Trypanosoma 
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brucei and of rat liver Thy-1 glycoproteinll as well as of 
related oligosaccharide fragments12 containing myo- or 
D-chiro-inositol have been described. 
Results and Discussion 
The synthesis of the conveniently functionalized D-chiro- 
inositol derivative (10) is shown in Scheme 1. Enone 6: 
available in multigram amounts from methyl a-D-glu- 
copyranoside by modification of a known procedure,13J4 
was further transformed into the key epoxide 8 as reported 
by Acid-catalyzed trans-diaxial openingls of the 
epoxide ring of 8 with allyl alcohol in the presence of boron 
trifluoride etherate afforded the D-chiro-inositol derivative 
9, which was transformed into 10 and 11 through tin- 
mediated regioselective alkylation.16 In compound 10 
positions 1 and 6 appear differentiated for further phos- 
phorylation and glycosylation. The complete sequence 
constitutes an effective method for the multigram-scale 
preparation of conveniently substituted D-chiro-inositol 
derivatives in which the nature and position of the 
protecting groups can be varied at will and represents a 
further example of the usefulness of the Ferrier's cw- 
bocyclization rea~ti0n.l~ The stereochemistry of 9 was 
unequivocally established (Scheme 1) by transformation 
into the previously knownls 1-0-methyl-D-chiro-inositol 
(13) and its penta-0-acetate 14. 
Glycosylation of the axial hydroxyl group of a D-chiro- 
inositol derivative has not been reported in the literature. 
However, a low reactivity was anticipated toward glycosyl 
donors bearing a nonparticipating nitrogen function at 
position 2, as required for the preparation of 1. According 
to previous experience,lob preliminary experiments indi- 
cated that the trichloroacetimidate pro~edure'~ gave the 
best yield and a-selectivity, and therefore, glycosyl donor 
15 was used.12b This trichloroacetimidate was readily 
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,I Reagents and conditions: (a) 1.3 equiv of TrCl, 0.16 equiv of 
DMAP, pyridine, rt, 16 h; (b) 7.2 equiv of NaH, 6.1 equiv of BnBr, 
DMF, rt, 3 h; (c) p-TsOH until pH < 4, MeOH/CHnClz (21), rt, 12 
h; (d) 2.9 equiv of Phap, 1.4 equiv of Cb, pyridine, rt, 12 h; (e) 5.7 
equiv of NaH, DMF, 20 h; (0 1.1 equiv of HgC12, MeZCO/H20 (2:1), 
100 OC, 1.5 h; (g) 2.7 equiv of MaC1,0.14 equiv of DMAP, pyridine, 
rt, 4 h; (h) 1.1 equiv of CeCl~7Hz0,  6.3 equiv of N a B h ,  MeOH, -50 
OC, 5 h; (i) 1.5 equiv of m-CPBA, CHzC12, rt, 24 h; c j )  6.5 equiv of allyl 
alcohol, 2.1 equiv of BFsaOEh, CHZC12, rt, 3.5 h; (k) 1.1 equiv of 
BuzSnO, 1.1 equiv BQNBr, 5.0 equiv of BnBr or 4.1 equiv of PMBCl, 
3-A MS, MeCN, 80 "C, 5 h; (1) 5.0 equiv of NaH, 5.0 equiv of BnBr, 
DMF, rt, 90 min; (m) cat. 10% Pd/C, cat. p-TsOH, 95% aqueous 
EtOH, 80 OC, 2 h; (n) 2.0 equiv of NaH, 2.5 equiv of MeI, DMF', rt, 
15 min; (0) cat. 10% Pd/C, HZ (1 atm), MeOH, rt, 14 h; (p) 50 equiv 
of Ac20, pyridine, rt, 16 h. 
available in multigram quantities from 1,6-anhydroman- 
nose.20*21 Reaction of 10 with 15 using trimethylsilyl triflate 
as promotor gave the corresponding a-glycoside 16 in 55 7% 
yield (Scheme 2). Deallylation22 and subsequent phos- 
phorylation using the phosphoramidite procedure23 gave 
18 which, after deacetylation and hydrogenation, afforded 
1. This is the first synthesis of a 6-0-glycosyl-D-chiro- 
inositol 1-phosphate. The preliminary synthesis by Falk 
et a1.12f gave a 2-0-glycosyl 1-phosphate compound and 
that reported by Shen et gave a 4-0-glycosyl 
1-phosphate. 
(20) Kloosterman, M.; de Nijs, M. P.; van Boom, J. H. J.  Carbohydr. 
(21) Jaramillo, C .  Ph.D. Thesis, Univereidad Comdutense, Madrid. 
Chem. 1986,5,215. 
1991. 
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Synthesis of Inositol 1-Phosphates 
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a Reagents and conditions: (a) 1.0 equiv of 10, 1.6 equiv of 15, 0.08 equiv of TMSOTf, CHzC12, -25 OC -. 23 OC, 3 h; (b) 0.04 equiv of 
[Ir(COD)(PhzMeP)z]PFe,Hz (1atm),THF,rt,5min;argon,30min,andthen2.3equivofI~,THF/H~0 (4 l ) , r t ,2  h; (c) 2.2equivofi-PrzNP(OBn)z, 
4.5 equiv of tetrazole, MeCN/CHZClZ (l : l) ,  rt, 1 h; (d) cat. RuClr3H20,4.5 equiv of NaIOd, CH2C12/MeCN/HzO (l:l:l),  rt, 1 h; (e) THF/10% 
NH3 in MeOH (1:3.2), 0 OC, 72 h; (0 cat. 10% Pd/C, MeOH-0.2 M NaOAc/HOAc pH 5 buffer (l:l),  rt, 18 h. 
Scheme 3 Blloo( OH + B ~ ~ o ~ o ~  
Brio OAll Brio OAll 
10 R = Bn 10 epi-10 
11 R = PMB 11 19 
65 % 
20, R = H, [U]O -30' 
21, R = Ac, [U]D -6.6" 
a Reagents and conditions: (a) 2.3 equiv of PCC, CHzC12, rt, 13 h; (b) see Table 1; (c) 2.0 equiv of NaH, 3.2 equiv of MeI, DMF, rt, 1 h; 
(d) cat. p-TsOH, cat. 10% Pd/C, 95% aqueous EtOH, 8OoC, 90 min; (e) H2 (1 atm), 95% aqueous EtOH, rt, 90 min; (0 52 equivof AczO, pyridine, 
rt, 16 h. 
For the synthesis of the myo-inositol derivative 2 ,  several 
attempts were made to invert the configuration of the free 
hydroxyl group of 10 or 11 conventionally, either through 
a Mitsunobu reactionz4 or by treatment of the cor- 
responding triflate with benzoyl nu~ leoph i l e s~~  with 
unsatisfactory results. Similarly, the attempted osmy- 
lation of 7 did not provide a convenient route for the gram- 
scale preparation of the desired myo-inositol compound. 
Therefore, a two-step oxidation-reduction sequence was 
preferred (Scheme 3). Thus, oxidation of either 10 or 11 
gave the corresponding ketones whose reduction was 
strongly dependent on steric and electronic factors. 
Lithium reagents seemed to favor a-delivery of hydride 
and only reducing agents bearing very large alkyl sub- 
stituents favored @-attack, away from the vicinal allyloxy 
group in axial position, providing the desired stereochem- 
(24) Mitaunobu, 0. Synthesis 1981, 1. 
(25) David, S.; Fernhdez-Mayoralas, A. Carbohydr. Res. 1987, 165, 
(211. 
istry (Table 1). Most likely, the orientation of the 
substituents a to the carbonyl function in the ketones 
allows complexation of these molecules by both faces. The 
configuration of 19 was unequivocally established by 
conversion into the previously known (-)-bornesitol(20) 
and its penta-0-acetate 21 (Scheme 3).% Phosphorylation 
of 19 gave 22 and subsequent acidolysis of the p- 
methoxybenzyl group afforded the myo-inositol derivative 
23, which is ready for glycosylation at  position 6 (Scheme 
4). Reaction of 23 with trichloroacetimidate 15, using 
TMSOTf as promotor, afforded glycoside 24 in 65 5% yield, 
which was completely deprotected to give 212a*d@ in 
moderate yield (Scheme 4). 
Experimental Section 
General. NMR spectra were recorded at 30 "C on Varian 
XL-300 (300 MHz) or Bruker AM-200 (200 MHz) instruments. 
Melting points were determined on a Kofler hot-stage apparatus 
(26) (a) Post, G. G.; Anderson, L. J.  Am. Chem. SOC. 1962,84,478. (b) 
Matauo, A.; Takaoka, D.; Kawahara, H. Phytochemistry 1986,25,2335. 
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Table 1. OH Inversion of 10 and 11 through an Oxidation-Reduction Seauence (see Scheme 3) 
reduction conditions after PCC oxidation of substrate 
substrate reagents solvent T ("0 products (ratio)o 
10 
10 
10 
10 
10 
10 
10 
10 
11 
11 
11 
11 
11 
11 
11 
11 
11 
NaBH4 
NaBH4 
NaBHJCeCl3 
L-Selectride 
DIBAL 
LiBH4 
NaBHJCeClS 
LiAlH4 
LiAl(0-t-Bu)sH 
LiAl(O+Bu)sH/HgCl2 
(R)-Alpine hydride 
(R)-Alpine hydride 
(8-Alpine hydride 
@)-Alpine hydride 
LiAlHd 
LiAl(0- t-Bu)aH 
LiAl(O-t-Bu),H 
MeOH 
MeOH 
MeOH 
THF 
THF 
THF 
THF 
THF 
MeOH 
THF 
THF 
EtzO 
EtzO 
THF 
THF 
THF 
THF 
0 
-78 
-78 
0 
0 
-78 
-78 
-78 
-78 
-78 
-78 
-78 
-78 
0 
-90 
0 
-90 
lO/epi-lO (1:l) 
10/epi-10 (1:l) 
10/epi-10 (32) 
10/epi-10 (101) 
10/epi-10 (51) 
10/epi-10 (7:l) 
lO/epi-lO (2.21) 
10/epi-10 (1.61) 
11/19 (1.2:l) 
11/19 (2.1:l) 
11/19 (2,l:l) 
11/19 (1.81) 
11/19 (2.21) 
11/19 (1:4.2) 
11/19 (1:6) 
11/19 (1:3) 
11/19 (1:5) 
0 Determined from the 1H NMR of the crude. 
Scheme 4 
PMBO 2: 
19 - a, b B ~ ~ o ~ O ' ~ & B n  2
84 % Brio OAll 
8 3 %  
22 
23 
0 Reagents and conditions: (a) 2.5 equiv of i-PrzNP(OBn)z, 3.0 equiv of tetrazole, MeCN/CH2Clz (l:l), rt, 1 h; (b) cat. RuCb.3H20,2.5 equiv 
of NaIO4, CHzC12/MeCN/H20 (l:l:l), rt 1 h; (c) CF3COzH 2.5% v/v in CH2C12, rt, 1 h; (d) 1.0 equiv of 23,2.6 equiv of 14,0.08 equiv of TMSOTf, 
CHZC12, -20 "C - 23 "C, 2.5 h; (e) THF/10% NH3 in MeOH (1:3.4), 0 "C, 68 h; (0 0.04 equiv of [Ir(COD)(Ph2MeP)zlPFe, Hz (1 atm), THF, 
rt, 5 min; argon 30 min, and then 2.0 equiv of 12, THF/H20 (4.2:1), rt, 2 h; (g) cat. 10% Pd/C, H2 (1 atm), 95% aqueous EtOH, rt, 18 h. 
and are uncorrected. Optical rotations were determined with a 
Perkin-Elmer 141 polarimeter. Elemental analyses were obtained 
with a Perkin-Elmer 240 instrument. Separation and purification 
of products was performed by flash chromatography using silica 
gel Merck (230-400 mesh). Silica gel plates (Merck, GFm) were 
used for analytical thin-layer chromatography (TLC). Tetrahy- 
drofuran (THF) and ethyl ether were distilled under argon from 
sodium-benzophenone, methylene chloride from calcium hydride, 
and dimethylformamide from barium oxide. All reactions were 
performed under an argon atmosphere with anhydrous, freshly 
distilled solvents, unless otherwise indicated. 
Methyl 2,3,4-Tri-Obenzyl-a-~glucopyranoeide (4).l3 To 
asolution of methyl a-D-glucopyranoside (3,19.40 g, 100.00 mmol) 
in pyridine (200 mL) were added TrCl (35.00 g, 125.67 mmol) 
and DMAP (2.00 g, 16.37 mmol). After 16 h, the solvent was 
evaporated, and the residue was crystallized (EtOH, 200 mL). 
The resulting crystalline methyl 6-O-trityl-a-~-glucopyranoside 
(36.34 g, 83%) was dissolved in DMF (400 mL) and treated with 
95% NaH (15.00 g, 606.25 mmol) and BnBr (60 mL, 86.34 g, 
504.91 mmol) a t  rt. After 3 h, the reaction was quenched with 
MeOH (150 mL), and the solvents were evaporated at  reduced 
pressure. The residue was dissolved in E t 0  (900mL) and washed 
with HoO (500 mL). The aqueous phase was extracted with Et20 
(2 X 250 mL), and the combined organics were washed with brine 
(200 mL), dried (NazSO4), and concentrated. The resulting 
residue was dissolved in MeOH-CH2C12 (2:1, 500 mL), and 
p-TsOH was added until pH < 4. After 12 h of stirring, the 
reaction was neutralized with EtsN, and the solvents were 
evaporated. E t 0  (400 mL) was added, and the organic phase 
was washed with Ha0 (500 mL). The aqueous phase was extracted 
with EtzO (2 X 100 mL), and the combined organics were washed 
with brine (200 mL), dried (Na2SO4), and concentrated. The 
resulting residue was purified by flash chromatography (hexane/ 
AcOEt 101  - 2:1), yielding 4l3 (36.70 g, 79% from 3). 
Methyl 2,3,4-Tri-0benzyl-cu-~-xyl~ hex-6-enopyranoside 
(6).14 To a solution of 3 (42.10 g, 90.73 mmol) in pyridine (500 
mL) were added Ph3P (68.00 g, 259.54 mmol) and CL (68.00 g, 
130.77 mmol). After 12 h, MeOH (120 mL) was added and the 
solvents were evaporated. The residue was dissolved in E t 0  
(500 mL) and washed with HzO (300 mL). The aqueous phase 
wasextractedwithEtO(3 X 100mL),andthecombinedorganics 
were washed with brine (200 mL), dried (NaZSOd), and concen- 
trated. The resulting residue was purified by flash chromatog- 
raphy (hexane/AcOEt 20:l - S l ) ,  affording methyl 2,3,4-tri- 
O-benzyl-6-iodo-6-deoxy-a-~-glucopyranoside (38.50 g, 74 % ). 
This product was dissolved in DMF (350 mL) and treated with 
95% NaH (9.60 g, 380.00 mmol). After 20 h, MeOH (200 mL) 
was added, the solvent was evaporated at  reduced pressure, and 
the resulting residue was suspended in H20 (200 mL). The 
aqueous phase was extracted with E t 0  (2 X 300 mL), the 
combined organics were washed with brine (200 mL), dried 
(NazSOd), and concentrated, and the resulting residue was purified 
by flash chromatography (hexane/AcOEt 15:l-c lOl), affording 
614 (25.50 g, 63% from 3). 
(2S,3R,45)-2,3,4-Trie(benzyloxy)cyclohex-S-enone (6).14 
To a solution of 6 (12.00 g, 26.91 mmol) in Me2CO-H*0 (2:1,800 
mL) was added HgCl2 (7.90 g, 29.10 mmol), and the resulting 
solution was heated at  100 "C for 90 min. The reaction was then 
cooled, and the solvent was evaporated at  reduced pressure. The 
residue was dissolved in E t 0  (300 mL) and washed with 10% 
aqueous KI (300 mL). The aqueous phase was extracted with 
EtzO (3 X 100 mL), and the combined organics were washed with 
brine (200 mL), dried (Na2SO,), and concentrated. The resulting 
residue was purified by flash chromatography (hexane/AcOEt 
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3:1), affording a mixture of epimers (9.88 g, 85%, a/p = 3.51 by 
lH NMR). To a solution of this mixture (6.30 g, 14.58 mmol) in 
pyridine (120 mL) were added MsCl (3 mL, 38.8 mmol) and 
DMAP (250 mg, 2.05 mmol). After 4 h, ice (100 g) was added, 
and the aqueous phase was extracted with EkO (3 x 100 mL). 
The solvents were evaporated at  reduced pressure, and the 
resulting residue was purified by flash chromatography (hexane/ 
AcOEt 101  - 4:1), affording 614 (4.86 g, 68% from 5). 
1,2,3-Tri-O-benzylconduritol B (7). To a solution of 6 (4.86 
g, 11.74 mmol) in MeOH (450 mL) at -50 "C was added 
CeClr7H20 (4.60g, 12.35mmol). After 10min of stirring, NaBH4 
(700 mg, 18.42 mmol) was added, and the reaction mixture was 
stirred at  -50 0C for 5 h. The reaction mixture was treated with 
MezCO (5 mL) at -50 "C and allowed to warm tort. The solvents 
were evaporated at  reduced pressure and the resulting residue 
was dissolved in EkO (100 mL) and washed with H2O (100 mL). 
The aqueous phase was washed with Et20 (100 mL), and the 
combined organics were concentrated, affording an epimeric 
mixture of alcohols (4.70 g, 97%, 14:l by lH NMR), which was 
submitted to epoxidation without further purification. A pure 
sample of 7 was obtained by flash chromatography (hexanel 
AcOEt 4:l- 2:l): mp 116-119 "c; [(u]23D +117' (c 0.9, CHC13), 
lit.27 +114.6'; lH NMR (200 MHz, C&) 6 7.40-7.20 (m, 15 H), 
5.23 (m, 2 H), 4.67-4.38 (m, 4 H), 4.19 (s,2 H), 3.92 (m, lH), 3.83 
(m, 1 H), 3.47 (dd, 1 H, J = 10.3,7.5 Hz), 3.17 (dd, lH, J = 10.3, 
7.7 Hz), 1.44 (d, 1 H, J = 4.4 Hz); 13C NMR (50 MHz, CDCls) 
6 138.6,129.4,128.6,128.4,127.9,127.8,127.7,127.6,127.0,84.3, 
83.3, 80.5, 75.3, 72.2, 71.9, 71.8. Anal. Calcd for C27H~04: C, 
77.87; H, 6.78. Found: C,77.60; H, 6.70. 
4,5,6-Tri-O-benzyl-l,2-anhydro-myo-inositol (8). To a 
solution of 7 (4.70 g, 11.30 mmol) in CHzClz (120 mL) was added 
55% m-CPBA (5.32 g, 16.97 mmol) at rt. After 24 h, CHzClz (80 
mL) was added, and the organic phase was washed with 10% 
Na2S2O3 (100 mL) and saturated aqueous NaHCO3 (100 mL). 
The solvent was evaporated at reduced pressure, and the resulting 
residue was purified by flash chromatography (hexane/AcOEt 
3:l - 1:l) to give 8 as a white solid (4.55 g, 93%): mp 147-150 
7.40-7.30 (m, 15 H), 4.94-4.63 (m, 6 H), 4.02 (dd, 1 H, J = 8.1, 
1.7 Hz), 3.93 (d, 1 H, J = 7.4 Hz), 3.48 (m, 2 H), 3.41 (m, 1 H), 
138.2,127.9,127.8,127.8,127.7,127.6,83.3,79.5,79.3,75.6,75.2, 
73.2, 71.9, 56.2, 53.6. Anal. Calcd for C27H2805: C, 74.98; H, 
6.52. Found: C, 75.10; H, 6.86. 
1-O-Allyl-2,3,4-tri-O-benzyl-~-ch~ro-inositol (9). To a 
solution of 8 (4.55 g, 10.53 mmol) in CHzCl2 (100 mL) were added 
allyl alcohol (4.69 mL, 68.81 mmol) and BFrOEb (2.70 mL, 21.94 
mmol). After 3.5 h, the reaction was neutralized with EtsN, 
CH2C12 (100 mL) was added, and the organic phase was washed 
with water (150 mL). The organic layer was dried (NazSO4) and 
evaporated at reduced pressure, and the resulting residue was 
purified by flash chromatography (hexane/AcOEt 2:l-  1:l) to 
give 9 as a syrup (3.87 g, 75%): + 40" (c 0.04, CHC1,); 'H 
NMR (300 MHz, CDC13) 6 7.26-7.15 (m, 15 H), 5.84-5.71 (m, 1 
H), 5.18-5.03 (m, 2 H), 4.91-4.52 (m, 6 H), 4.15-3.94 (m, 3 H), 
3.84-3.72 (m, 4 H), 3.52 (t, 1 H, J = 8.9 Hz); 13C NMR (50 MHz, 
127.7, 127.6, 127.5, 127.4, 117.1, 81.6,81.5,80.2, 75.6,75.5,75.3, 
73.1, 72.5, 71.3, 69.5. Anal. Calcd for C30HMOS: C, 73.45; H, 
6.99. Found: C, 73.12; H, 6.87. 
1-OAllyl-2,3,4,5-tetra-O-benzyl-~-ch~~inositol(lO). To 
a solution of 9 (275 mg, 0.561 mmol) in MeCN (20 mL) were 
added BuzSnO (145 mg, 0.582 mmol), Bu4NBr (185 mg, 0.574 
mmol), powdered 3-A molecular sieves (2.0 g), and BnBr (0.33 
mL, 2.77 mmol), and the resulting solution was heated at  80 "C. 
After 5 h, the reaction was cooled and filtered through a pad of 
Celite. The filter was washed with CHzCl2 (2 X 10 mL), and the 
filtrate and washings combined were evaporated at  reduced 
pressure. The resulting residue was purified by flash chroma- 
tography (hexane/AcOEt 4:1,2.7 X 14.0 cm) to give 10 as a syrup 
(270 mg, 83%): lH NMR (300 MHz, CDCl3) 6 7.27-7.15 (m, 20 
H), 5.81-5.70 (m, 1 H), 5.17-5.03 (m, 2 H), 4.86-4.54 (m, 8 H), 
4.17-3.90 (m, 3 H), 3.84-3.66 (m, 5 H); 13C (50 MHz, CDCl3) 6 
"C; [CY]"D +78" ( C  0.4, CHC13); 'H NMR (300 MHz, CDCl3) 6 
3.23 (d, 1 H, J = 3.8 Hz); I3C NMR (50 MHz, CDC13) 6 138.3, 
CDCl3) 6 138.8,138.7,138.5,135.0,128.6,128.3,128.1,128.0,127.9, 
139.0,138.95,138.7,138.1,135.1,128.5,128.3,128.0,127.9,127.7, 
127.4,116.8,81.9,81.6,80.3,79.9,75.8,75.7,75.6,73.3,72.5,68.2. 
1,2,3,4,5-Penta-O-benzyl-D-chiro-inositol(12). To a solu- 
tion of 9 (590 mg, 1.20 mmol) in DMF (20 mL) were added 80% 
NaH (180 mg, 6.00 mmol) and BnBr (0.72 mL, 6.06 mmol) at rt. 
After 90 min, MeOH (0.5 mL) was added and the solvents were 
evaporated at  reduced pressure. The residue was dissolved in 
CHzCl2 (30 mL) and washed with HzO (20 mL). The organic 
layer was dried (Na~S04) and concentrated. The crude was 
dissolved in 95% EtOH (60 mL), treated with 10% Pd/C (320 
mg) and p-TsOH (65 mg), and heated at 80 "C.% After being 
stirred for 2 h at  80 "C, the reaction was cooled to rt and filtered 
through a pad of Celite, washing with CHzClz (20 mL) and MeOH 
(20mL). The fiitrateand the washingscombined wereevaporated 
at reduced pressure, and the resulting residue was purified by 
flash chromatography (hexane/AcOEt 5:l) to give 12 (410 mg, 
54%). 
1-0-Methyl-D-chiro-inositol ( 13).18 To a solution of 12 (410 
mg, 0.651 mmol) in DMF (15 mL) were added 80% NaH (39 mg, 
1.30 mmol) and Me1 (0.1 mL, 1.62 mmol). After 15 min, MeOH 
(0.1 mL) was added, and the solvents were evaporated at reduced 
pressure. The residue was dissolved in CHzCl2 (15 mL) and the 
solution was washed with HzO (15 mL), dried (Na2S04), and 
concentrated at reduced pressure. The crude was dissolved in 
MeOH (40 mL), 10% Pd/C (168 mg) wasadded, and the mixture 
was stirred under Hz (1 atm) at  rt. After 14 h, the reaction mixture 
was filtered through a pad of Celite, the filter was washed with 
MeOH (2 X 15 mL), and the filtrate and washings combined 
were evaporated at  reduced pressure. The resulting reeidue was 
purified by flash chromatography (CH2CldMeOH 2:1,2.7 X 10.5 
cm) to give 13 (80mg, 63% ): [(Y]23D +59' (c 1.3, DzO), lit.18 +61°; 
lH, J = 9.5,3.4 Hz), 3.46 (dd, 1 H, J = 3.4,8.1 Hz), 3.44 (t, 1 H, 
J = 3.4 Hz), 3.35 (t, 1 H, J = 9.5 Hz) and 3.33 (dd, 1 H, J = 9.5, 
8.1 Hz). 
1,2,3,4,6-Penta- Oacetyl-6- Omet hyl-~-chhwinosito1 (14).18 
13 (40 mg, 0.206 mmol) was acetylated (pyridine, 2 mL; AczO, 
1 mL) to give 14 as a white solid: mp 106-110 OC, lit.l8 mp 
'H-NMR (300 MHz, D2O) 6 4.02 (t, 1 H, J = 3.4 Hz), 3.57 (dd, 
110.5-111.5 'c; [aIz3~ + 26.0' (C 1.7, CHCl,), lit.18 +29.1'; 'H 
NMR (200MH2, C&) 6 5.91 (dd, lH, J= 10.0,9.5 Hz), 5.82 (dd, 
1 H, J = 10.0,9.5 Hz), 5.76 (dd, 1 H, J = 4.0, 3.6 Hz), 5.59 (dd, 
1 H, J = 10.0,3.6 Hz), 5.53 (dd, 1 H, J = 10.0,3.2), 3.03 (s,3 H), 
3.59 (dd, 1 H, J = 4.0,3.2), 1.73, 1.69, 1.68, 1.64 and 1.52 (5 s, 3 
H each); "C (50 MHz, C&) 6 169.6,169.55, 169.5,169.35,169.3, 
76.9, 71.3, 70.9, 70.5, 69.7, 67.6, 59.0, 20.2, 19.9. 
6- OAcetyl-2-azido-3,4-di- O-benzyl-2-deoxy-~-D-glucopy- 
ranosyl Trichloroacetimidate ( 15).12b To a solution of 6-0- 
acetyl-2-azido-3,4-di-O-~nzyl-2-deoxy-~-~-glucopyranose~~~ (200 
mg, 0.47 mmol) and CCbCN (680 mg, 4.71 mmol) in 3 mL of 
CH2C12 was added powdered, flame-dried KzCO3 (65 mg, 0.47 
mmol) at  23 "C. After 1 h of stirring, the suspension was filtered 
through a pad of Celite and the filtrate was concentrated at  
reduced pressure. The residue was quickly purified by flash 
chromatography (hexane/EtOAc 3:l) to give 15 as a white solid 
(262 mg, 98%, >95% f i  anomer by lH NMR). 
1-(6- O-Acetyl-2-azido-2-deoxy-3,4-dibenzyl-(u-~-glucopy- 
ranosyl)-6-~~~l-2,3,4~-tetra-~benzyl-~-c~inosito~(l6). 
A mixture of 10 (214 mg, 0.37 mmol) and 15 (137 mg, 0.23 mmol), 
azeotroped with freshly distilled benzene (2 X 10 mL), was 
dissolved in CH2Clp (3 mL). The solution was cooled to -25 OC 
and treated with CF3SOzSiMe3 (95 pL of a 0.2 M solution in 
C&C1~,0.019 mmol). After being stirred at -25 "C for 30 min, 
the solution was allowed to warm to rt over 3 h, and EtsN (0.6 
mL), AczO (0.2 mL), and DMAP (5 mg) were added. After 4 h 
of stirring, MeOH (0.5 mL) was added, the solution was stirred 
for 5 min, and the solvent was removed at reduced pressure. The 
residue was purified by flash chromatography (hexane/EtOAc 
9:1- 5:l) to give 16 as a colorless syrup (124 mg, 55%): [(uIz3D 
+40.8" (c 1.03, CHC1,); lH NMR (300 MHz, C&) 6 7.42-7.07 (m, 
30H),5.82(m, l H ,  J=  17.2,10.6,5.5Hz),5.21 (m, lH ,  J=  17.2, 
1.7 Hz), 5.04 (m, 1 H, J = 10.6, 1.5 Hz), 5.01-4.68 (m, lOH), 
4.57-4.47 (m, 4 H), 4.34-4.27 (m, 1 H), 4.19-3.92 (m, 6 H), 3.80 
(dd,lHJ=4.1,1.3Hz),3.57 (dd,lHJ=9.9,9.0Hz),3.15(dd, 
(27) Vasa, G.; Krausz, P.; Quiclet-Sire, B.; Delaumeny, J.-M.; Cleophax, 
J.; Gero, S. R. Acad. Sci. Paris, SQr. I2 1985, 301, 1345. (28) Boss, R.; Scheffold, R. Angew. Chem., Znt. Ed. Engl. 1976,15,558. 
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1H,J~10.1,3.5),1.67(~,3H);'3C(50MH~,C~~)6169.6,139.8, 
139.7, 138.8, 138.4, 135.4, 128.5-127.5 (obscured by solvent 
signals), 116.6, 96.5, 82.4, 80.6, 80.5, 78.6, 78.5, 76.0, 75.7, 75.3, 
75.0,74.6,74.5,73.7,73.6,73.1,69.7,64.3,62.6,20.4. Anal. Calcd 
for C ~ ~ O l l H ~ N 3 :  C, 71.57; H, 6.41; N, 4.24. Found C, 71.28; H, 
6.70; N, 4.45. 
1-( 6- O-Acetyl-2-azido-2-deoxy-3,4-dibenzyl-~~-~-glucopy- 
ranosyl)-2,3,4,5-tetra-O-benzyl-~-c~~inositol (17). To a 
solution of 16 (124 mg, 0.125 mmol) in THF (4 mL) under argon 
was added [Ir(COD)(PhzMeP)z]PFe (4 mg, 4.8 X 1V mmol) at  
rt. The argon atmosphere was replaced with Hz and the solution 
was stirred for 5 min, during which time the initially slightly red 
suspension becomes colorless. The Hz was replaced with argon 
again, the solution was stirred for 1 h, and water (1.0 mL) and 
1 2  (74 mg) were added. After 2 h of stirring, the reaction mixture 
was diluted with EtOAc (25 mL), washed with 10% aqueous 
NazSz03 (20 mL) and brine (10 mL), dried (NazSOd), and 
concentrated at reduced pressure. The residue was purified by 
flash chromatography (hexane/EtOAc 3:l- 3:2) to give 17 as a 
colorless oil (101 mg, 85%): 'H NMR (300 MHz, c a s )  6 7.40- 
7.04 (m, 30 H), 5.04-4.48 (m, 12 H), 4.44 (d, 1 H, J = 3.5 Hz), 
4.29-3.88 (m, 10 H), 3.55 (dd, J = 10.1, 9.0 Hz), 3.09 (dd, 1 H, 
J = 10.2, 3.5 Hz), 2.36 (bs, 1 H), 1.66 (8,  3 H). 
2,3,4,5-Tri- 0-benzyl- 1-(6-Oacetyl-2-azido-2-deoxy-3,4-di- 
O-benzyl-cu-~-glucopyranosyl)-6-(dibenzylphosphono)-~- 
chiro-inositol(l8). To a solution of 17 (85 mg, 0.089 mmol) in 
MeCN-CHzClZ (1 mL, 1:l) were added dibenzyl N,N-diisopro- 
pylphosphoramidite (69 mg, 0.20 mmol) and tetrazole (28 mg, 
0.40 "4). After being stirred for 1 hat  rt, the reaction mixture 
was diluted with water (0.5 mL) and treated with NaIO, (68 mg, 
0.40 mmol) and RuCla-BHzO (0.5 mg). After being stirred 
vigorously for 1 h, the reaction mixture was diluted with CHzClz 
(25 mL) and washed with water (10 mL). The aqueous layer was 
extracted with CHzClz (2 x 20 mL). The combined organic 
extracts were dried (NazSO4) and concentrated at reduced 
pressure. The residue was purified by flash chromatography 
(hexane/EtOAc 3:l - 32) to give 18 as a colorless oil (88 mg, 
6 7.54-7.04 (m,40H), 5.20 (m, lH,  J =  7.2,3.9,3.1 Hz), 5.08-4.28 
(m, 20 H), 4.56 (d, 1 H, J = 3.6 Hz), 4.12-3.93 (m, 5 H), 3.55 (t, 
1 H, J = 9.2 Hz), 3.07 (dd, 1 H, J = 10.1, 3.5 Hz), 1.69 (s, 3 H); 
127.5 (obscured by solvent signals), 97.1, 81.9, 81.6, 80.7, 78.4, 
64.3, 62.6, 20.4. Anal. Calcd for C ,~H,ZN~O~~P:  C, 69.47; H, 
6.00; N, 3.47. Found C, 69.71; H, 6.30; N, 3.71. 
Sodium 1-(2-am~o-~-deoxy-a-~-g~ucopyranosy~)-~c~~ 
inositol 1-Hydrogen Phosphate (1). A solution of 18 (80 mg, 
0.066 mmol) in THF (2.5 mL) and 10% NH3 in MeOH (8 mL) 
was kept at  0 "C for 72 h. The solvent was removed at reduced 
pressure and the residue was purified by flash chromatography 
to give unreacted 18 (13 mg, 16 % ) and its deacetylated derivative 
(52 mg, 67%): 'H NMR (300 MHz, C a s )  6 7.52-7.01 (m, 40 H,), 
5.23 (m, 1 H, J = 8.5, 3.2 Hz), 5.12-4.52 (m, 17 H), 4.47 (t, 1 H, 
J =  3.6Hz),4.31 (m, l H ,  J =  9.6,2.8Hz),4.26 (m, l H ,  J =  10.0, 
2.7 Hz), 4.15-3.94 (m, 4 H), 3.60 (t, 1 H, J = 9.6 Hz), 3.58 (bs, 
3 H), 3.10 (dd, 1 H, J = 10.1, 3.6 Hz). A solution of the latter 
compound (147 mg, 0.126 mmol) in MeOH (15 mL) and 0.2 M 
NaOAc/HOAc pH 5 buffer (15 mL) was stirred under Hz (1 atm) 
in the presence of 10% Pd/C (100 mg) at  rt. After 18 hof stirring, 
the suspension was filtered through a pad of Celite and the filtrate 
was passed through a column of Na-exchanged Amberlite IR- 
120. The resultant solution was lyophilized and the residue was 
purified by column chromatography on Sephadex G-15 (HzO) to 
give 1 as a white solid (34 mg, 40% from 18): [a]% +99.9" (c 
4.41 (m, 1 H), 4.23 (t, 1 H, J = 3.4 Hz), 3.97 (dt, 1 H, J = 10.0, 
2.9 Hz), 3.85-3.64 (m, 5 H), 3.58-3.49 (m, 2 H), 3.44 (W, lH,  J 
= 9.9 Hz), 3.31 (dd, lH,  J = 10.7, 3.7 Hz); '3C NMR (50 MHz, 
DzO) 6 95.4 (br), 76.9, 74.1, 73.6, 73.5, 71.4 (br), 70.9, 70.5, 70.3, 
61.2, 55.0 (br). 
1- O-Allyl-2,3,4-tri- 0 benzyl-5- 0-(p-methoxybenzy1)-D- 
chjro-inositol (11). To a solution of 9 (3.50 g, 7.14 mmol) in 
MeCN (120 mL) were added BuzSnO (1.92 g, 7.71 mmol), 
BuNBr (2.42 g, 7.52 mmol), powdered 3-A molecular sieves (15.0 
82%): [cY]'~D +58.1' (C 0.34, CHCl3); 'H NMR (300 MHz, C a s )  
'WNMR (50MHz,C&) 6 169.7,139.5,138.7,138.6,138.4,128.9- 
77.9, 76.1, 75.8, 75.3, 75.0, 74.2 (d, Jcp = 2.0 Hz), 73.1, 72.7 (d, 
Jcp = 5.5 Hz), 69.9,69.8 (d, Jcp = 5.8 Hz), 69.4 (d Jcp = 5.5 Hz), 
1.022, HzO); 'H NMR (300 MHz, DzO) 6 5.23 (d, 1 H, J = 3.7 Hz), 
g), and PMBCl(4.00 mL, 29.52 mmol), and the resulting solution 
was heated at  80 'C. After 5 h, the reaction was cooled and 
filtered through a pad of Celite. The filter was washed with 
CHzCl2 (2 X 40 mL), and the fitrate and washings combined 
were evaporated at reduced pressure. The resulting residue was 
purified by flash chromatography (hexane/AcOEt 5:l- 21) to 
give 11 as a colorless syrup (3.70 g, 85%): [a]% + 1.5' (c 1.3, 
5.65 (m, 1 H), 5.12-4.80 (m, 6 H), 4.55 (d, 1 H), 4.45 (d, 1 H), 4.41 
(d, 1 H), 4.29 (d, 1 H), 4.18-4.07 (m, 2 H), 4.03 (dd, 1 H, J = 2.6, 
9.8 Hz), 3.91-3.78 (m, 5 H), and 3.18 (s,3 H); 13C NMR (50 MHz, 
C a s )  6 159.9,140.0,140.0,139.5,135.7,130.0,129.8,129.5,128.9, 
128.5, 128.4, 128.3, 128.0, 127.8, 127.5, 127.4, 116.8, 114.1,82.6, 
82.2,80.7,80.4,76.7,75.85,75.8,73.4,73.1,69.1,54.7. Anal.Calcd 
for C&O,: C, 74.73; H, 6.93. Found: C, 74.57; H, 6.99. 
2-O-Allyl-3,4,5-tri-O-benzyl-6-O-~methoxybenzyl)-myo- 
inositol (19). To a solution of 11 (3.39 g, 5.56 "01) in CHzClz 
(80 mL) was added PCC (2.72 g, 12.62 mmol) at rt. After being 
stirred for 13 h, the reaction mixture was filtered through a pad 
of Celite, the filter was washed with CHZClz (2 X 25 mL), and the 
filtrate and washings combined were evaporated at  reduced 
pressure. The resulting residue was purified by flash chroma- 
tography (hexane/AcOEt 81 - 41) to give the ketone as a 
colorless syrup (3.00 g, 89%). To a solution of the ketone (3.00 
g, 4.93 "01) in THF (100 mL), at  -90 "C, was added a solution 
of (R)-Alpine hydride (0.5 M in THF, 21.0 mL, 10.50 mmol) in 
THF (40 mL). After 30 min, the reaction was warmed to 0 OC, 
and water (46 mL), 3 M NaOH (14 mL), and 30% HzOz (30 mL) 
were added. After 30 min, the reaction was warmed to 22 "C, 
HzO (250 mL) was added, the aqueous phase was extracted with 
E t 0  (2 X 250 mL), and the solvent was evaporated at  reduced 
pressure. The resulting residue was purified by flash chroma- 
tography (hexane/AcOEt 41 - 3:l) to give 11 (0.70 g) and 19 as 
a white solid (1.95 g, 58% from starting 11). 19: mp 89-91 'C; 
6.81 (m, 19 H), 5.96-5.85 (m, 1 H), 5.28-5.12 (m, 2 H), 4.91-4.66 
(m, 8 H), 4.45-4.15 (m, 2 H), 3.97 (t, 1 H, J = 9.5 Hz), 3.91 (t, 
CHCls); 'H NMR (300 MHz, C a s )  6 7.33-6.62 (m, 19 H), 5.78- 
[ ( Y ] ~ D  - 8.0' (C 0.95, CHCb); 'H NMR (300 MHz, CDCla) 6 7.33- 
lH,J=2.6H~),3.76(~,3H),3.74(t,lH,J=9.5H~),3.45-3.36 
(m, 3 H), and 2.19 (d, 1 H, J = 6.2 Hz); "C (50 MHz, C&) 6 159.3, 
138.7,138.2,135.3,129.6,128.4,128.0,127.7,127.6,127.5,116.7, 
113.9,83.6,81.9,81.1,77.2,76.7,75.9,75.7,75.2,73.7,73.0,72.3, 
55.3. Anal. Calcd for C & 4 ~ 0 , :  C, 74.73; H, 6.93. Found C, 
74.36; H, 7.15. 
2- O-Allyl-3,4,5-tri- 0-benzyl- 1- O( dibenzy1phosphono)-6- 
O(pmethoxybenzyl)-D-myo-inositol (22). To a solution of 
19 (340 mg, 0.56 mmol) in CHzC12/MeCN (l:l, 5 mL) were added 
tetrazole (120 mg, 1.67 mmol) and N,N-dibenzyldiisopropyl- 
phoephoramidite (480 mg, 1.39 "01). After being stirred for 
1.5 h at rt, the reaction mixture was cooled to 0 "C and HzO (2.5 
mL), NdO4 (300 mg, 1.39 mmol) and RuC13.3Hz0 (1 mg) were 
added. The resulting mixture was vigorously stirred at  0 "C for 
0.5 h. The reaction mixture was diluted with CHzCll (60 mL), 
washed with 10% aqueous NazSzOa (10 mL), and brine (10 mL), 
dried (Na#O4), and evaporated at  reduced pressure. The residue 
was purified by flash chromatography (hexane/EtOAc 3:l) to 
give 22 as a white solid (397 mg, 83%): mp 85-87 'c; [CYIz3D 
(m, 27 H), 6.76-6.72 (m, 2 H), 5.92 (m, 1 H, J = 17.2, 10.4, 5.6, 
5.3 Hz), 5.25 (m, 1 H, J = 17.2, 1.8, 1.6 Hz), 5.11 (m, 1 H, J = 
10.4,10.4,1.8,1.5Hz),5.05-4.57(m,12H),4.37(m,1H,J=12.9, 
5.6,1.6 Hz), 4.27-4.17 (m, 3 H), 4.03 (t, J = 9.4 Hz), 4.01 (t, 1 H, 
J = 9.6 Hz), 3.74 (s, 3 H), 3.44 (t, 1 H, J = 9.2 Hz), 3.37 (dd, 1 
+6.0° (C 0.905, CHCls); 'H NMR (300 MHz, CDCl3) 6 7.46-7.36 
H, J = 9.9, 2.2 Hz); lac NMR (50 MHz, CDCla) 6 138.6, 138.5, 
138.0, 135.7 (d, Jcp = 7.2 Hz), 135.2, 130.6, 129.3, 128.5, 128.3, 
128.2, 127.9, 127.8, 127.7, 127.6, 127.5, 127,4, 116.3, 113.6, 83.1, 
81.2,80.4,79.9(d,Jcp=7.2H~),78.5,(d,Jcp=6.2H~),77.6,77.0, 
76.4, 75.8,75.2, 73.9,72.6, 69.3 (d, Jcp = 5.4 Hz), 69.2 (d, Jcp = 
5.2 Hz), 55.1. Anal. Calcd for CszHMOl& C, 71.70; H, 6.37. 
Found C, 71.51; H, 6.60. 
2-OAllyl-3,4,5-tri-Obenzyl-l-O(dibenzylphosphono)-~- 
myo-inositol (23). To a solution of 22 (100 mg, 0.11 mmol) in 
CHzClz (1 mL) was added CF3COzH (2 mL of a 2.5% v/v solution 
in CH2C12) at  23 "C. After being stirred for 1 h at  room 
temperature, the reaction mixture was diluted with CHzClz (25 
mL) and washed with saturated aqueous NaHCOs, the aqueous 
phase was extracted with CHzClz (3 X 20 mL), the combined 
Synthesis of Inositol 1-Phosphates 
organic extrach were dried (Na2SO4), and the solvent was removed 
at reduced pressure. The residue was purified by flash chro- 
matography (hexane/EtOAc 2:l) to give 23 as a white solid (72 
mg, 84%): mp 102-104 "c; [ L U ] ~ D  +6.3" (C 0.238, CHCl3); 'H 
NMR (300 MHz, CDCb) 6 7.24-7.13 (m, 25 H), 5.75 (m, 1 H, J 
= 17.2, 10.4, 5.5, 5.2 Hz), 5.09 (m, 1 H, J = 17.2, 1.7, 1.6 Hz), 
5.01-4.88 (m, 5 H), 4.81-4.66 (m, 4 H), 4.50 (m, 2 H), 4.15 (m, 
1 H, J = 12.9, 5.5, 1.7 Hz), 4.06-3.98 (m, 3 H), 3.90 (t, 1 H, J = 
Hz), 3.20 (t, 1 H, J = 9.1 Hz), 2.68 (bs); l3C NMR (50 MHz, 
Hz), 135.1,128.6,128.5,128.4,128.35,128.3,128.2,128.0,127.95, 
2.1Hz,H-2),3.85(t,lH, J=9.5Hz) ,3 .23(dd, lH,J=9.8 ,2 .3  
CDC13) 6 138.6,138.0,135.7 (d, Jcp = 7.0 Hz), 135.6 (d, Jcp = 7.1 
127.9, 127.7, 127.6, 127.5, 116.4,82.9, 80.9,80.4, 78.8 (d, Jcp = 6 
Hz), 77.6,77.0,76.4,75.85 (d, Jcp = 2.7 Hz), 75.7,75.5,73.9,72.7, 
72.1 (d, Jcp = 4.9 Hz), 69.65 (d, Jcp = 5.9 Hz), 69.4 (d, Jcp = 5.6 
Hz). Anal. Calcd for C~H1708P: C, 70.39; H, 6.31. Found: C, 
70.30; H, 6.12. 
(-)-D-Bornesitol (20).26a To a solution of 19 (305 mg, 0.500 
mmol) in DMF (10 mL) were added 97 % NaH (25 mg, 1.00mmol) 
and Me1 (0.10 mL, 1.62 mmol). After 1 h of stirring, MeOH (1 
mL) and Ht0  (30 mL) were added, the aqueous phase was 
extracted with Et20 (2 X 20 mL), and the combined organic 
extracts were washed with brine (200 mL), dried (Na2S041, and 
concentrated at reduced pressure. The resulting residue was 
purified by flash chromatography (hexane/AcOEt 4:l) to give 
the pure methyl ether (250 mg, 80%). A solution of this prcduct 
in 95% EtOH (20 mL) was treated with p-TsOH (40 mg) and 
10% Pd/C (150mg)at8OoCfor90min. Thereactionwasallowed 
to cool to rt and was stirred under H2 (1 atm). After 90 min, the 
reaction mixture was filtered through a pad of Celite, the filter 
was washed with MeOH (2 X 20 mL), and the filtrate and washings 
combined were evaporated at reduced pressure. The resulting 
residue was purified by flash chromatography (CH&12/MeOH 
2:1) to give 2026a (63 mg, 65% from 19): [(u]23D-300 (c  0.25, DzO), 
lit.2b -32O; 1H NMR (200 MHz, D2O) 6 4.21 (t, 1 H, J = 2.7 Hz), 
3.55 (dd, 1 H, J = 10.0,9.5 Hz), 3.52 (dd, 1 H, J = 10.0,9.0 Hz), 
3.39 (dd, 1 H, J = 10.0, 2.7 Hz), 3.33 (s, 3 H), 3.17 (dd, 1 H, J 
= 9.5, 9.0 Hz), 3.11 (dd, 1 H, J = 10.0, 2.8 Hz). 
2,3,4,5,6-Penta-O-acetyl-l-O-methyl-myo-inositol (21).26b 
22 (63 mg, 0.101 mmol) was acetylated (pyridine, 1 mL; Ac20, 
0.5 mL) to give 21:mb mp 143-146 "C, lit.26b mp 142-143.5 "C; 
[a]~-8.6" (c 1.1, CHCl~),lit.2~b-9.30;1HNMR(300MHz,CDCl~) 
6 5.74 (t, 1 H, J = 2.8 Hz), 5.48 (dd, lH,  J = 10.5, 10.0 Hz), 5.37 
(dd, 1 H, J = 10.1,g.g Hz), 5.12 (dd, 1 H, J = 10.0 Hz), 4.96 (dd, 
1 H, J = 10.5, 2.8 Hz), 3.41 (dd, 1 H, J = 10.1, 2.8 Hz), 3.35 (e, 
3 H), 2.19 (s, 3 H), 2.05 (s, 6 H), 2.01 (s, 6 H). 
2-0-Allyl-3,4,5-tri- 0-benzyl- 1- O-(dibenzylphosphono)-6- 
(6- O-acetyl-2-azido-3,4-di- O-benzyl-2-deoxy-a-~-glucopyra- 
nosyl)-D-myo-inosito1(24). Amixtureof23 (151 mg,0.20mmol) 
and 15 (293 mg, 0.51 mmol) was azeotroped with freshly distilled 
benzene (2 X 10mL) anddissolved in CHzCl2 (3 mL). Thesolution 
was cooled to -20 "C and treated with CF3S02SiMe3 (85 pL of 
a 0.2 M solution in CH2C12,0.017 mmol). After being stirred for 
2 h at -20 "C, the reaction mixture was allowed to warm tor t  over 
a period of 0.5 h, diluted with CHzCl2 (20 mL), washed with 
saturated aqueous NaHC03 (10 mL) and brine (10 mL), dried 
(Na2S04), and concentrated at reduced pressure. The resulting 
residue was purified by flash chromatography (hexane/EtOAc 
4:l) to give 24 as a clear oil (151 mg, 65%): [a]23D +47.4O (c 0.527, 
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CHCl,); lH NMR (300MHz, Ca6)  6 7.37-7.05 (m, 35 H,), 6.03- 
5.87 (m, 1 H), 5.69 (d, 1 H, J = 3.6 Hz), 5.35-5.24 (m, 1 H), 
5.17-4.17 (m, 24 H), 3.98 (dd, 1 H J = 12.4, 3.7 Hz), 3.49 (dd, 1 
H, J = 9.8, 8.7 Hz), 3.37 (t, 1 H, J = 9.2 Hz), 3.14 (dd, 1 H, J = 
9.8, 2.1 Hz), 3.00 (dd, 1 H, J = 10.2, 3.6 Hz), 1.54 (8,  3 H); 13C 
136.6,136.4,128.8-127.5 (obscured by solvent signals), 116.3,97.8, 
= 5.3 Hz), 69.6 (d, Jcp = 6.1 Hz), 63.8, 63.7, 20.4. Anal. Calcd 
for CwH,0N3O14P: C, 68.32; H, 6.08; N, 3.62. Found C, 68.48; 
H, 6.31; N, 3.70. 
3,4,5-Tri-O-benzyl- 1- O-(dibenzylphosphono)-6-(2-azido- 
2-deoxy-3,4-dibenzyl-a-~glucopyranosyl)-~-myo-~~i~l(!45). 
A solution of 24 (120 mg, 0.103 mmol) in THF (3.5 mL) and 10% 
NH3 in MeOH (12 mL) was kept at 0 OC for 68 h. The reaction 
mixture was concentrated at reduced pressure and the residue 
was purified by flash chromatography (hexane/EtOAc 4 1  - 3:l) 
to give unreacted24 (15 mg, 12 %) and ita deacetylated derivative 
(65 mg, 56%) as a clear oil. To a solution of the latter compound 
(65 mg, 0.058 mmol) in 2.5 mL of THF under argon at rt was 
added [Ir(COD)(PhzMeP)2]PF6 (2 mg, 2.4 X 1V mmol). The 
argon atmosphere was replaced with H2 and the solution was 
stirred for 5 min. The H2 was replaced with argon, the solution 
was stirred 30 min, and 1 2  (30 mg) and water (0.6 mL) were added. 
After stirring for 2 h, the reaction mixture was diluted with EtOAc 
(80 mL), washed with 10% aqueous Na2S203 (15 mL) and brine 
(10 mL), dried (Na2SO4), and concentrated at reduced pressure. 
The residue was purified by flash chromatography (hexane/ 
EtOAc 1:l) to give 25 as a clear oil (34 mg, 54%): lH NMR (300 
MHz, CSDS) 6 7.43-7.00 (m, 35 HI, 5.78 (d, 1 H, J = 3.8 Hz), 
5.25-4.61 (m, 14 H), 4.49-4.31 (m, 3 H), 4.28-4.20 (m, 2 H), 4.16 
(t, 1 H, J = 9.5 Hz), 3.75 (dd, 1 H, J = 9.7, 9.2 Hz), 3.45 (dd, 1 
H, J = 12.2, 1.9 Hz), 3.43 (dd, 1 H, J = 12.2, 2.2 Hz), 3.32 (t, 1 
H, J = 9.4 Hz), 3.18 (dd, 1 H, J = 10.4, 3.8 Hz), 3.11 (dd, 1 H, 
J = 9.5, 2.5 Hz), 2.22 (br, 2 H). 
6-( 2-Amino-2-deoxy-a-~-glucopyranosyl)-D-my~~nos~- 
to1 1-Phosphate (2).l%d,e A suspension containing 25 (34 mg, 
0.032 mmol) and 10% Pd/C (30 mg) in EtOH (10 mL) was 
vigoruosly stirred under Hz (1 atm) at rt. After 18 h, the 
suspension was filtered through a pad of Celite and the filter was 
rinsed with EtOH (5 mL) and water (2 X 5 mL). The filtrate and 
the washings combined were concentrated at reduced pressure 
and the resulting aqueous solution was lyophilized to give 2 as 
a white solid (12.2 mg, 91 %): [ a ] 2 9 ~  +73.2" (c 0.608, HzO), lit.'" 
H, J = 3.8 Hz), 4.08 (bs, 1 H), 4.04 (br d, 1 H, J = 9.2 Hz), 3.98 
(dt, 1 H, J = 10.2, 3.5 Hz), 3.80 (t, 1 H, J = 9.2 Hz), 3.78 (dd, 1 
H, J = 10.4, 9.4 Hz), 3.71-3.70 (m, 2 H), 3.58 (W, 1 H, J = 9.7 
Hz), 3.44 (br d, 1 H, J = 9.7 Hz), 3.42 (t, 1 H, J = 9.6 Hz), 3.30 
(t, 1 H, J = 10.3 Hz), 3.23 (dd, 1 H, J = 10.6, 3.8 Hz); 13C NMR 
Hz), 74.0, 73.6, 73.3, 72.8, 71.7, 71.4, 70.4, 61.2, 55.1; 31P NMR 
(121.4 MHz, D20, pH 11, ext ref H3P04) 6 3.21. 
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NMR (50 MHz, C a s )  6 169.6,139.4, 138.75, 138.7, 138.5, 136.7, 
82.0,81.3,80.8,79.9 (d, Jcp = 8.3 Hz), 78.7,76.6,76.0,75.6,75.1, 
74.9 (d, Jcp = 9.0 Hz), 74.6,72.7,69.9 (d, 74.6, 72.7,69.9 (d, Jcp 
[CY]"D +62O (C 0.3, H2O); 'H NMR (300 MHz, DnO) 6 5.49 (d, 1 
(50 MHz, D2O) 6 96.6, 78.4 (d, Jcp = 5.2 Hz), 77.3 (d, Jcp = 4.1 
